Posts
ICON recently increased its expectations for earnings this year. The 2008 earnings per diluted share rose from $1.27 to $1.29, up from $1.23 to $1.26.
ICON CEO Peter Gray had this to say about the increase in earnings:
“For 2008 overall, we expect to report revenues in the range of $862 to $865 million, which is a modest reduction in previous guidance reflecting the impact of currency volatility over the last six months.”
This comes at a time when most CROs are lowing their profit and revenue outlooks. For more, read the article at Clinical Trials Today.
About
